Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Heart Transplant Failure
Locations
- Karine Nubret, Bordeaux, France
- Laurent Sebbag, Lyon, France
- Claire Garandeau, Nantes, France
- Bertrand Lelong, Rennes, France